An Nrf2 target gene, Nqo1, is increased in the hippocampus [57, 58] and frontal cortex (although less strongly than in the hippocampus) [31], whereas HO-1 is increased in the temporal cortex and hippocampus of AD human brains [29, 30]. This evidence concerns the gene NQO1 and Alzheimer disease.